Summary

According to this study, the global Nasal Drug Delivery Technology market size will reach US$ 79520 million by 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Nasal Drug Delivery Technology Industry Forecast” looks at past sales and reviews total world Nasal Drug Delivery Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Nasal Drug Delivery Technology sales for 2025 through 2031. With Nasal Drug Delivery Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nasal Drug Delivery Technology industry.
This Insight Report provides a comprehensive analysis of the global Nasal Drug Delivery Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nasal Drug Delivery Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nasal Drug Delivery Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nasal Drug Delivery Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nasal Drug Delivery Technology.
This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Drug Delivery Technology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pressurized Type
Non-pressurized Type
Segmentation by Application:
Nasal Congestion
Rhinitis
Asthma
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
3M United States
Aegis Therapeutics LLC
Aptargroup, Inc.
Becton, Dickinson and Company
BF Ascher & Company, Inc.
Cadila Pharmaceuticals Ltd
Dickinson and Company
Douglas Pharmaceuticals Ltd
ENT Technologies Pty. Ltd
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
OptiNose, Inc
PendoPharm, Inc
Pfizer, Inc
Promius Pharma, LLC
Shin Nippon Biomedical Laboratories

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nasal Drug Delivery Technology Market Size (2020-2031)
2.1.2 Nasal Drug Delivery Technology Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nasal Drug Delivery Technology by Country/Region (2020, 2024 & 2031)
2.2 Nasal Drug Delivery Technology Segment by Type
2.2.1 Pressurized Type
2.2.2 Non-pressurized Type
2.3 Nasal Drug Delivery Technology Market Size by Type
2.3.1 Nasal Drug Delivery Technology Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nasal Drug Delivery Technology Market Size Market Share by Type (2020-2025)
2.4 Nasal Drug Delivery Technology Segment by Application
2.4.1 Nasal Congestion
2.4.2 Rhinitis
2.4.3 Asthma
2.4.4 Other
2.5 Nasal Drug Delivery Technology Market Size by Application
2.5.1 Nasal Drug Delivery Technology Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nasal Drug Delivery Technology Market Size Market Share by Application (2020-2025)
3 Nasal Drug Delivery Technology Market Size by Player
3.1 Nasal Drug Delivery Technology Market Size Market Share by Player
3.1.1 Global Nasal Drug Delivery Technology Revenue by Player (2020-2025)
3.1.2 Global Nasal Drug Delivery Technology Revenue Market Share by Player (2020-2025)
3.2 Global Nasal Drug Delivery Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nasal Drug Delivery Technology by Region
4.1 Nasal Drug Delivery Technology Market Size by Region (2020-2025)
4.2 Global Nasal Drug Delivery Technology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nasal Drug Delivery Technology Market Size Growth (2020-2025)
4.4 APAC Nasal Drug Delivery Technology Market Size Growth (2020-2025)
4.5 Europe Nasal Drug Delivery Technology Market Size Growth (2020-2025)
4.6 Middle East & Africa Nasal Drug Delivery Technology Market Size Growth (2020-2025)
5 Americas
5.1 Americas Nasal Drug Delivery Technology Market Size by Country (2020-2025)
5.2 Americas Nasal Drug Delivery Technology Market Size by Type (2020-2025)
5.3 Americas Nasal Drug Delivery Technology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nasal Drug Delivery Technology Market Size by Region (2020-2025)
6.2 APAC Nasal Drug Delivery Technology Market Size by Type (2020-2025)
6.3 APAC Nasal Drug Delivery Technology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nasal Drug Delivery Technology Market Size by Country (2020-2025)
7.2 Europe Nasal Drug Delivery Technology Market Size by Type (2020-2025)
7.3 Europe Nasal Drug Delivery Technology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nasal Drug Delivery Technology by Region (2020-2025)
8.2 Middle East & Africa Nasal Drug Delivery Technology Market Size by Type (2020-2025)
8.3 Middle East & Africa Nasal Drug Delivery Technology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nasal Drug Delivery Technology Market Forecast
10.1 Global Nasal Drug Delivery Technology Forecast by Region (2026-2031)
10.1.1 Global Nasal Drug Delivery Technology Forecast by Region (2026-2031)
10.1.2 Americas Nasal Drug Delivery Technology Forecast
10.1.3 APAC Nasal Drug Delivery Technology Forecast
10.1.4 Europe Nasal Drug Delivery Technology Forecast
10.1.5 Middle East & Africa Nasal Drug Delivery Technology Forecast
10.2 Americas Nasal Drug Delivery Technology Forecast by Country (2026-2031)
10.2.1 United States Market Nasal Drug Delivery Technology Forecast
10.2.2 Canada Market Nasal Drug Delivery Technology Forecast
10.2.3 Mexico Market Nasal Drug Delivery Technology Forecast
10.2.4 Brazil Market Nasal Drug Delivery Technology Forecast
10.3 APAC Nasal Drug Delivery Technology Forecast by Region (2026-2031)
10.3.1 China Nasal Drug Delivery Technology Market Forecast
10.3.2 Japan Market Nasal Drug Delivery Technology Forecast
10.3.3 Korea Market Nasal Drug Delivery Technology Forecast
10.3.4 Southeast Asia Market Nasal Drug Delivery Technology Forecast
10.3.5 India Market Nasal Drug Delivery Technology Forecast
10.3.6 Australia Market Nasal Drug Delivery Technology Forecast
10.4 Europe Nasal Drug Delivery Technology Forecast by Country (2026-2031)
10.4.1 Germany Market Nasal Drug Delivery Technology Forecast
10.4.2 France Market Nasal Drug Delivery Technology Forecast
10.4.3 UK Market Nasal Drug Delivery Technology Forecast
10.4.4 Italy Market Nasal Drug Delivery Technology Forecast
10.4.5 Russia Market Nasal Drug Delivery Technology Forecast
10.5 Middle East & Africa Nasal Drug Delivery Technology Forecast by Region (2026-2031)
10.5.1 Egypt Market Nasal Drug Delivery Technology Forecast
10.5.2 South Africa Market Nasal Drug Delivery Technology Forecast
10.5.3 Israel Market Nasal Drug Delivery Technology Forecast
10.5.4 Turkey Market Nasal Drug Delivery Technology Forecast
10.6 Global Nasal Drug Delivery Technology Forecast by Type (2026-2031)
10.7 Global Nasal Drug Delivery Technology Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nasal Drug Delivery Technology Forecast
11 Key Players Analysis
11.1 3M United States
11.1.1 3M United States Company Information
11.1.2 3M United States Nasal Drug Delivery Technology Product Offered
11.1.3 3M United States Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 3M United States Main Business Overview
11.1.5 3M United States Latest Developments
11.2 Aegis Therapeutics LLC
11.2.1 Aegis Therapeutics LLC Company Information
11.2.2 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Offered
11.2.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Aegis Therapeutics LLC Main Business Overview
11.2.5 Aegis Therapeutics LLC Latest Developments
11.3 Aptargroup, Inc.
11.3.1 Aptargroup, Inc. Company Information
11.3.2 Aptargroup, Inc. Nasal Drug Delivery Technology Product Offered
11.3.3 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Aptargroup, Inc. Main Business Overview
11.3.5 Aptargroup, Inc. Latest Developments
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Information
11.4.2 Becton, Dickinson and Company Nasal Drug Delivery Technology Product Offered
11.4.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Becton, Dickinson and Company Main Business Overview
11.4.5 Becton, Dickinson and Company Latest Developments
11.5 BF Ascher & Company, Inc.
11.5.1 BF Ascher & Company, Inc. Company Information
11.5.2 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Offered
11.5.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 BF Ascher & Company, Inc. Main Business Overview
11.5.5 BF Ascher & Company, Inc. Latest Developments
11.6 Cadila Pharmaceuticals Ltd
11.6.1 Cadila Pharmaceuticals Ltd Company Information
11.6.2 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Offered
11.6.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cadila Pharmaceuticals Ltd Main Business Overview
11.6.5 Cadila Pharmaceuticals Ltd Latest Developments
11.7 Dickinson and Company
11.7.1 Dickinson and Company Company Information
11.7.2 Dickinson and Company Nasal Drug Delivery Technology Product Offered
11.7.3 Dickinson and Company Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Dickinson and Company Main Business Overview
11.7.5 Dickinson and Company Latest Developments
11.8 Douglas Pharmaceuticals Ltd
11.8.1 Douglas Pharmaceuticals Ltd Company Information
11.8.2 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Offered
11.8.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Douglas Pharmaceuticals Ltd Main Business Overview
11.8.5 Douglas Pharmaceuticals Ltd Latest Developments
11.9 ENT Technologies Pty. Ltd
11.9.1 ENT Technologies Pty. Ltd Company Information
11.9.2 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Offered
11.9.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 ENT Technologies Pty. Ltd Main Business Overview
11.9.5 ENT Technologies Pty. Ltd Latest Developments
11.10 Glaxosmithkline PLC
11.10.1 Glaxosmithkline PLC Company Information
11.10.2 Glaxosmithkline PLC Nasal Drug Delivery Technology Product Offered
11.10.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Glaxosmithkline PLC Main Business Overview
11.10.5 Glaxosmithkline PLC Latest Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Nasal Drug Delivery Technology Product Offered
11.11.3 Johnson & Johnson Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Johnson & Johnson Main Business Overview
11.11.5 Johnson & Johnson Latest Developments
11.12 Merck & Co., Inc.
11.12.1 Merck & Co., Inc. Company Information
11.12.2 Merck & Co., Inc. Nasal Drug Delivery Technology Product Offered
11.12.3 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Merck & Co., Inc. Main Business Overview
11.12.5 Merck & Co., Inc. Latest Developments
11.13 Novartis AG
11.13.1 Novartis AG Company Information
11.13.2 Novartis AG Nasal Drug Delivery Technology Product Offered
11.13.3 Novartis AG Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Novartis AG Main Business Overview
11.13.5 Novartis AG Latest Developments
11.14 OptiNose, Inc
11.14.1 OptiNose, Inc Company Information
11.14.2 OptiNose, Inc Nasal Drug Delivery Technology Product Offered
11.14.3 OptiNose, Inc Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 OptiNose, Inc Main Business Overview
11.14.5 OptiNose, Inc Latest Developments
11.15 PendoPharm, Inc
11.15.1 PendoPharm, Inc Company Information
11.15.2 PendoPharm, Inc Nasal Drug Delivery Technology Product Offered
11.15.3 PendoPharm, Inc Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 PendoPharm, Inc Main Business Overview
11.15.5 PendoPharm, Inc Latest Developments
11.16 Pfizer, Inc
11.16.1 Pfizer, Inc Company Information
11.16.2 Pfizer, Inc Nasal Drug Delivery Technology Product Offered
11.16.3 Pfizer, Inc Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Pfizer, Inc Main Business Overview
11.16.5 Pfizer, Inc Latest Developments
11.17 Promius Pharma, LLC
11.17.1 Promius Pharma, LLC Company Information
11.17.2 Promius Pharma, LLC Nasal Drug Delivery Technology Product Offered
11.17.3 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Promius Pharma, LLC Main Business Overview
11.17.5 Promius Pharma, LLC Latest Developments
11.18 Shin Nippon Biomedical Laboratories
11.18.1 Shin Nippon Biomedical Laboratories Company Information
11.18.2 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Offered
11.18.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Shin Nippon Biomedical Laboratories Main Business Overview
11.18.5 Shin Nippon Biomedical Laboratories Latest Developments
12 Research Findings and Conclusion